Last News

Besides following our news, follow us on socials networks :

New H.I.V. long-term remission reported in a second patient, a huge milestone in the Global AIDS Epidemic 5 March 2019

TransCure is proud to serve researchers in the field by providing suitable HIV mouse disease models.

Read more
They talk about us in Labiotech – Immuno-Oncology 6 February 2019

Find more about how TransCure improves immuno-oncology research with its humanized mouse model.

Read more
Microchip-based mouse identification system 5 February 2019

TransCure bioServices improves animal health and wellbeing by using microchip-based identification system in order to deliver the best quality data to the customers.

Read more
2018 achievements and new objectives in 2019 24 January 2019

TransCure bioServices shares with you its major achievements in 2018 and its objectives 2019.

Read more
TransCure bioServices involved in Targovax’s results 19 December 2018

Targovax demonstrates the “Synergistic effect of oncolytic virus combined with anti-PD-1 against Melanoma”. TransCure’s hu-mouse are the preferred in vivo models for combination therapy evaluation.

Read more
TransCure will be waiting you at the second edition of I4ID 4 December 2018

Besides being present at I4ID event, Sébastien Tabruyn, our CSO, will give a pitch for answering one question : “How humanized mice models helps to evaluate immunotherapy for infectious Diseases?”

Read more